Targeting PI3K/mTOR pathway in hepatocellular carcinoma
Hepatocellular carcinoma (HCC), mammalian target of rapamycin (mTOR), phospho inositide 3 kinase (PI3K). - Hepatozelluläres Karzinom, Säuger-Zielgen für Rapamycin, Phosphoinositol 3 Kinase
